SAM supplementation can delay ALS onset in mouse models by 2–3 weeks and mitigate neurodegenerative characteristics, including preventing motor neuron loss, reducing gliosis, and inhibiting SOD1 aggregation.302 SOD1 mutations are considered an oxidative stress-inducing factor in the pathogenesis of ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.